Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Clark

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Orthodontics|July 2, 2003
Soft tissue changes in patients with Class II Division 1 malocclusions treated using Twin Block appliances: finite-element scaling analysisG D Singh, W J Clark
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|April 12, 2001
Localization of mandibular changes in patients with class II division 1 malocclusions treated with twin-block appliances: finite element scaling analysisG D Singh, W J Clark
European Journal of Clinical Pharmacology|June 8, 2006
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?David W J Clark, Johanna Strandell
BMJ (Clinical Research Ed.)|December 4, 2004
Sibutramine may be associated with memory impairmentDavid W J Clark, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|June 12, 2004
Nose bleeds associated with use of risperidoneMira Harrison-Woolrych, David W J Clark
Expert Opinion on Drug Safety|October 27, 2004
Disturbance of vision by COX-2 inhibitorsDavid M Coulter, David W J Clark
Current Drug Safety|August 12, 2008
The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactionsDavid W J Clark, Mira Harrison-Woolrych
Drug Safety|May 15, 2004
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiologyDavid W J Clark, Deborah Layton, Saad A W Shakir
International Journal of Obesity (2005)|February 24, 2006
Bruising associated with sibutramine: results from postmarketing surveillance in New ZealandM Harrison-Woolrych, G R Hill, D W J Clark
Free Radical Research Communications|January 1, 1989
Theoretical studies of molecular mechanisms of DNA damage induced by hydroxyl radicalsR Osman, W J Clark, A P Mazurek, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Orthodontics|July 2, 2003
Soft tissue changes in patients with Class II Division 1 malocclusions treated using Twin Block appliances: finite-element scaling analysisG D Singh, W J Clark
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|April 12, 2001
Localization of mandibular changes in patients with class II division 1 malocclusions treated with twin-block appliances: finite element scaling analysisG D Singh, W J Clark
European Journal of Clinical Pharmacology|June 8, 2006
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?David W J Clark, Johanna Strandell
BMJ (Clinical Research Ed.)|December 4, 2004
Sibutramine may be associated with memory impairmentDavid W J Clark, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|June 12, 2004
Nose bleeds associated with use of risperidoneMira Harrison-Woolrych, David W J Clark
Expert Opinion on Drug Safety|October 27, 2004
Disturbance of vision by COX-2 inhibitorsDavid M Coulter, David W J Clark
Current Drug Safety|August 12, 2008
The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactionsDavid W J Clark, Mira Harrison-Woolrych
Drug Safety|May 15, 2004
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiologyDavid W J Clark, Deborah Layton, Saad A W Shakir
International Journal of Obesity (2005)|February 24, 2006
Bruising associated with sibutramine: results from postmarketing surveillance in New ZealandM Harrison-Woolrych, G R Hill, D W J Clark
Free Radical Research Communications|January 1, 1989
Theoretical studies of molecular mechanisms of DNA damage induced by hydroxyl radicalsR Osman, W J Clark, A P Mazurek, et al.
Pageof 3